Wendy Lin

Wendy Lin

Auto-generated profile, based on publicly available information

Wendy Lin

Program for Computational and Systems Biology, Memorial Sloan-Kettering Cancer Center, New York, New York

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2023 in Cancer Research
Verified
Journal Article
Open access
PDF file
DMDeepti Mathur
Deepti Mathur
CLChen Liao
Chen Liao
WLWendy Lin
Wendy Lin
AFAlessandro La Ferlita
Alessandro La Ferlita
Salvatore AlaimoSalvatore Alaimo
Salvatore Alaimo
JXJoao B. Xavier
Joao B. Xavier
Understanding the rewired metabolism underlying organ-specific metastasis in breast cancer could help identify strategies to improve the treatment and prevention of metastatic disease. Here, we used a systems biology approach to compare metabolic fluxes used by parental breast cancer cells and their brain- and lung-homing derivatives. Divergent lineages had distinct, heritable metabolic fluxes. Lung-homing cells maintained high glycolytic flux despite low levels of glycolytic intermediates, constitutively activating a pathway sink into lactate. This strong Warburg effect was associated with a high ratio of lactate dehydrogenase (LDH) to pyruvate dehydrogenase (PDH) expression, which correlated with lung metastasis in patients with breast cancer. Although feature classification models trained on clinical characteristics alone were unable to predict tropism, the LDH/PDH ratio was a significant predictor of metastasis to the lung but not to other organs, independent of other transcriptomic signatures. High lactate efflux was also a trait in lung-homing metastatic pancreatic cancer cells, suggesting that lactate production may be a convergent phenotype in lung metastasis. Together, these analyses highlight the essential role that metabolism plays in organ-specific cancer metastasis and identify a putative biomarker for predicting lung metastasis in patients with breast cancer. Significance: Lung-homing metastatic breast cancer cells express an elevated ratio of lactate dehydrogenase to pyruvate dehydrogenase, indicating that ratios of specific metabolic gene transcripts have potential as metabolic biomarkers for predicting organ-specific metastasis.

13 October 2023
Verified
Other
Open access
DMDeepti Mathur
Deepti Mathur
CLChen Liao
Chen Liao
WLWendy Lin
Wendy Lin
AFAlessandro La Ferlita
Alessandro La Ferlita
Salvatore AlaimoSalvatore Alaimo
Salvatore Alaimo
JXJoao B. Xavier
Joao B. Xavier
Understanding the rewired metabolism underlying organ-specific metastasis in breast cancer could help identify strategies to improve the treatment and prevention of metastatic disease. Here, we used a systems biology approach to compare metabolic fluxes used by parental breast cancer cells and their brain- and lung-homing derivatives. Divergent lineages had distinct, heritable metabolic fluxes. Lung-homing cells maintained high glycolytic flux despite low levels of glycolytic intermediates, constitutively activating a pathway sink into lactate. This strong Warburg effect was associated with a high ratio of lactate dehydrogenase (LDH) to pyruvate dehydrogenase (PDH) expression, which correlated with lung metastasis in patients with breast cancer. Although feature classification models trained on clinical characteristics alone were unable to predict tropism, the LDH/PDH ratio was a significant predictor of metastasis to the lung but not to other organs, independent of other transcriptomic signatures. High lactate efflux was also a trait in lung-homing metastatic pancreatic cancer cells, suggesting that lactate production may be a convergent phenotype in lung metastasis. Together, these analyses highlight the essential role that metabolism plays in organ-specific cancer metastasis and identify a putative biomarker for predicting lung metastasis in patients with breast cancer.Significance:Lung-homing metastatic breast cancer cells express an elevated ratio of lactate dehydrogenase to pyruvate dehydrogenase, indicating that ratios of specific metabolic gene transcripts have potential as metabolic biomarkers for predicting organ-specific metastasis.

24 November 2025
Verified
Other
Open access
DMDeepti Mathur
Deepti Mathur
CLChen Liao
Chen Liao
WLWendy Lin
Wendy Lin
AFAlessandro La Ferlita
Alessandro La Ferlita
Salvatore AlaimoSalvatore Alaimo
Salvatore Alaimo
JXJoao B. Xavier
Joao B. Xavier
Supplementary figures and figure legends

16 September 2024
Verified
Other
Open access
PDF file
DMDeepti Mathur
Deepti Mathur
CLChen Liao
Chen Liao
WLWendy Lin
Wendy Lin
AFAlessandro La Ferlita
Alessandro La Ferlita
Salvatore AlaimoSalvatore Alaimo
Salvatore Alaimo
JXJoao B. Xavier
Joao B. Xavier
Supplementary figures and figure legends

24 November 2025
Verified
Other
Open access
DMDeepti Mathur
Deepti Mathur
CLChen Liao
Chen Liao
WLWendy Lin
Wendy Lin
AFAlessandro La Ferlita
Alessandro La Ferlita
Salvatore AlaimoSalvatore Alaimo
Salvatore Alaimo
JXJoao B. Xavier
Joao B. Xavier
Understanding the rewired metabolism underlying organ-specific metastasis in breast cancer could help identify strategies to improve the treatment and prevention of metastatic disease. Here, we used a systems biology approach to compare metabolic fluxes used by parental breast cancer cells and their brain- and lung-homing derivatives. Divergent lineages had distinct, heritable metabolic fluxes. Lung-homing cells maintained high glycolytic flux despite low levels of glycolytic intermediates, constitutively activating a pathway sink into lactate. This strong Warburg effect was associated with a high ratio of lactate dehydrogenase (LDH) to pyruvate dehydrogenase (PDH) expression, which correlated with lung metastasis in patients with breast cancer. Although feature classification models trained on clinical characteristics alone were unable to predict tropism, the LDH/PDH ratio was a significant predictor of metastasis to the lung but not to other organs, independent of other transcriptomic signatures. High lactate efflux was also a trait in lung-homing metastatic pancreatic cancer cells, suggesting that lactate production may be a convergent phenotype in lung metastasis. Together, these analyses highlight the essential role that metabolism plays in organ-specific cancer metastasis and identify a putative biomarker for predicting lung metastasis in patients with breast cancer.Significance:Lung-homing metastatic breast cancer cells express an elevated ratio of lactate dehydrogenase to pyruvate dehydrogenase, indicating that ratios of specific metabolic gene transcripts have potential as metabolic biomarkers for predicting organ-specific metastasis.

16 September 2024
Verified
Other
Open access
PDF file
DMDeepti Mathur
Deepti Mathur
CLChen Liao
Chen Liao
WLWendy Lin
Wendy Lin
AFAlessandro La Ferlita
Alessandro La Ferlita
Salvatore AlaimoSalvatore Alaimo
Salvatore Alaimo
JXJoao B. Xavier
Joao B. Xavier
Supplementary figures and figure legends